Moreover, we show that MAP3K3 inhibition, achieved through RNAi-mediated knockdown or pharmacological means, overcomes CDK4/6 inhibitor resistance in luminal breast cancer cells. The gene discussed is MAP3K3; the disease is breast carcinoma.